|
|
Volumn 23, Issue 5, 2005, Pages 519-521
|
|
Gene therapy: Cursed or inching towards credibility?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOTECHNOLOGY;
GENE THERAPY;
GENES;
BILIRUBIN;
BLOOD CLOTTING FACTOR 9;
DNA;
HYPOXIA INDUCIBLE FACTOR 1ALPHA;
PIGMENT EPITHELIUM DERIVED FACTOR;
VASCULOTROPIN;
ANGINA PECTORIS;
ARTERY DISEASE;
BIOTECHNOLOGY;
CORONARY ARTERY DISEASE;
CRIGLER NAJJAR SYNDROME;
CYSTIC FIBROSIS;
GENE THERAPY;
HUMAN;
MUSCULAR DYSTROPHY;
PANCREAS CANCER;
PRIORITY JOURNAL;
RETINA MACULA DEGENERATION;
RHEUMATOID ARTHRITIS;
SHORT SURVEY;
SOLID TUMOR;
ULTRAVIOLET RADIATION;
ARTICLE;
DRUG DESIGN;
DRUG INDUSTRY;
GENE TRANSFER;
GENETIC ENGINEERING;
INTERNATIONAL COOPERATION;
METHODOLOGY;
BIOTECHNOLOGY;
DRUG DESIGN;
DRUG INDUSTRY;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
GENETIC ENGINEERING;
INTERNATIONALITY;
|
|
EID: 22844435328
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0505-519 Document Type: Short Survey |
|
Times cited : (31)
|
|
References (0)
|